Ganoderma lucidum 'Blue Reishi'

Ganoderma lucidum 'Blue Reishi' is a color variant of the Reishi mushroom complex, presumed to contain triterpenoids (such as ganoderic acids) and beta-glucan polysaccharides similar to other Reishi variants. Current available research is limited to cultivation and extraction methodology, with no published clinical trials confirming health outcomes specific to this variant.

Origin & History

Ganoderma lucidum 'Blue Reishi' is a cultivar variant of the Reishi mushroom, cultivated on solid-state fermentation substrates containing sawdust and wheat bran, requiring approximately 4 months for complete cultivation cycles. The fruiting bodies are harvested, dried at 35°C, and processed through ethanol maceration extraction yielding approximately 13.19% of bioactive compounds.

Historical & Cultural Context

No historical or traditional use information was included in the provided cultivation-focused research sources. The dossier lacks ethnobotanical or traditional medicine documentation.

Health Benefits

• No clinical health benefits can be substantiated from the provided research
• The research focuses exclusively on cultivation and extraction methods
• No human studies, clinical trials, or health outcome data were included
• No evidence quality can be assessed without clinical research
• Traditional use claims cannot be verified from these cultivation-focused sources

How It Works

Like other Ganoderma lucidum variants, Blue Reishi is presumed to exert immunomodulatory effects via beta-glucan polysaccharides binding to Dectin-1 receptors on macrophages and dendritic cells, triggering NF-kB pathway activation. Ganoderic acids, lanostane-type triterpenoids, are theorized to inhibit 5-alpha reductase and modulate cytokine signaling cascades including TNF-alpha and IL-6 suppression. However, no molecular pathway data specific to the Blue Reishi variant has been confirmed in peer-reviewed clinical or preclinical human-cell studies.

Scientific Research

No clinical trials or meta-analyses were found in the provided research dossier. The available sources contain only cultivation and extraction methodology without any PMIDs or clinical outcome data.

Clinical Summary

No clinical trials, human studies, or controlled preclinical studies specifically investigating Ganoderma lucidum 'Blue Reishi' as a distinct variant have been identified in the available research literature. Existing data pertains solely to cultivation protocols and extraction techniques, making it impossible to assess efficacy or assign an evidence grade for any health outcome. Extrapolation from broader Ganoderma lucidum research—which includes small randomized trials in fatigue and immune function with modest effect sizes—cannot be applied to this specific variant without confirmatory data. The evidence quality for Blue Reishi-specific health claims is currently insufficient to support any therapeutic recommendation.

Nutritional Profile

Ganoderma lucidum 'Blue Reishi' shares the foundational biochemical composition of the Ganoderma lucidum species complex, with strain-specific variations likely present. Based on established Ganoderma lucidum compositional data: Macronutrients per 100g dry weight: protein 10-19g (containing all essential amino acids, notably glutamic acid, aspartic acid, and lysine); carbohydrates 26-28g; fat 1.9-3.9g (predominantly unsaturated fatty acids including oleic and stearic acid); dietary fiber 31-59g (predominately insoluble chitin-based fiber with low bioavailability). Key bioactive compounds: Beta-glucans (primarily beta-1,3/1,6-glucans) estimated 10-50% of dry weight depending on extraction method and fruiting body vs. mycelium source; triterpenoids (ganoderic acids A, B, C, D, G, H, and lucidenic acids) concentrated in fruiting body at approximately 1-6% dry weight, with higher concentrations in the spore wall; polysaccharides (Ganoderan A, B, C) ranging 1.0-1.5% in hot-water extracts. Micronutrients: potassium 310-460mg/100g; phosphorus 180-220mg/100g; calcium 20-60mg/100g; magnesium 14-25mg/100g; zinc 1.5-4.0mg/100g; selenium 0.01-0.19mg/100g (highly substrate-dependent); ergosterol (provitamin D2 precursor) 0.3-0.8% dry weight, converting to vitamin D2 upon UV exposure. B-vitamins present including niacin (3-4mg/100g), riboflavin (0.2-0.4mg/100g), and pantothenic acid. The 'Blue Reishi' designation likely refers to a specific cultivar or regional variant; pigmentation differences may indicate altered secondary metabolite profiles, but specific compositional data distinguishing this variant from standard G. lucidum is not established in peer-reviewed literature. Bioavailability note: Raw fruiting body compounds have significantly limited bioavailability due to chitin cell walls; hot-water extraction improves polysaccharide availability, while ethanol or dual extraction is required for triterpene bioavailability. Spore oil preparations yield highest triterpene concentrations.

Preparation & Dosage

No clinically studied dosage ranges were found in the provided research. The sources only describe extraction yields (13.19% from dry fruiting bodies) without human dosing information. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cannot be determined from cultivation-only research

Safety & Interactions

No safety profile specific to Ganoderma lucidum 'Blue Reishi' has been established in clinical literature, though general Reishi mushroom use has been associated with dry mouth, dizziness, gastrointestinal upset, and rare hepatotoxicity with prolonged use. Reishi variants may potentiate anticoagulant medications such as warfarin by inhibiting platelet aggregation, and caution is warranted when combined with antihypertensive or immunosuppressive drugs. Individuals with autoimmune conditions, bleeding disorders, or scheduled surgery should consult a physician before use. Pregnancy and lactation safety for this specific variant is entirely unstudied and its use during these periods cannot be considered safe by available evidence.